EDTUTC-4 New YorkLog in Sign up

INBX
Inhibrx Biosciences, Inc. Common Stock
stockNASDAQ

At CloseOct 2, 2026 3:59:59 PM EDT

96.90USD-1.052%(-1.03)201,448

Loading…

Loading…

1.42B

Healthcare

Biotechnology

HQ

La Jolla, CA, USA

132

Previous Close

$97.93

Beta

2.58

52-Week High

$155.29 2026-04-22

52-Week Low

$28.16 2025-10-23

SMA 50

$101.98

SMA 200

$91.07

Avg. Vol 10D

259,840

Avg. Vol 30D

339,887

Avg. Vol 90D

311,323

Relative Vol

0.59

14.72M

10.87M

73.84%

3,393,511

Short Interest %

31.23%

8.31

On/Off Exchange

61%/39%

70.32%

Short Vol % (off-exch)

59.85%

0.3100%

600,000

61

26

61

Nov 13, 2026 (39d)

Sep 24, 2026

11:12 AM EDTThursday 9/24 Insider Buying Report: GME, INBX ·

BNK Invest

Sep 15, 2026

08:29 PM EDTInhibrx Founder and CEO Mark Lappe Buys 25,000 Shares for $2.6 Million. What Does His Confidence Tell Investors? ·

The Motley Fool

Sep 1, 2026

01:00 PM EDTChondrosarcoma Clinical Trial Pipeline: Emerging Therapies and Key Developments Shaping the Treatment Landscape | DelveInsight ·

GlobeNewswire Inc.

INBX Performance

Period	Price	Date	Change	Beta
1W	101.71	2026-09-28	-4.82%	-0.211
1M	121.17	2026-09-04	-20.10%	2.080
3M	97.14	2026-07-06	-0.34%	1.555
6M	63.72	2026-04-06	+51.93%	2.379
1Y	35.65	2025-10-03	+171.56%	2.576
2Y	14.76	2024-10-04	+555.89%	—
5Y	31.14	2021-10-04	+210.89%	0.704

INBX Stock Summary

Inhibrx Biosciences, Inc. Common Stock (NASDAQ:INBX) stock price today is $96.81, and today's volume is 201,448. INBX is down 1.144% today. The 30 day average volume is 339,887. INBX market cap is $1.42B with 14.72M shares outstanding.